Sesen Bio Inc. [NASDAQ: SESN] surged by $0.33 during the normal trading session on Monday and reaching a high of $0.5933 during the day while it closed the day at $0.59. The company report on March 2, 2023 that Sesen Bio Stockholders Approve Merger with Carisma Therapeutics.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Declares Special Dividend in the Aggregate of $75 Million.
Approximately 88% Voted in Favor of the Merger at the Special Meeting.
Sesen Bio Inc. stock has also gained 142.20% of its value over the past 7 days. However, SESN stock has inclined by 156.95% in the 3 months of the year. Over the past six months meanwhile, it has gained 104.88% and gained 131.87% year-on date.
The market cap for SESN stock reached $112.95 million, with 202.78 million shares outstanding and 187.20 million shares in the current float. Compared to the average trading volume of 2.64M shares, SESN reached a trading volume of 5766042 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Sesen Bio Inc. [SESN]:
H.C. Wainwright have made an estimate for Sesen Bio Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 16, 2021. The new note on the price target was released on June 11, 2019, representing the official price target for Sesen Bio Inc. stock.
The Average True Range (ATR) for Sesen Bio Inc. is set at 0.04, with the Price to Sales ratio for SESN stock in the period of the last 12 months amounting to 2.82. The Price to Book ratio for the last quarter was 0.75, with the Price to Cash per share for the same quarter was set at 0.87.
SESN stock trade performance evaluation
Sesen Bio Inc. [SESN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 142.20. With this latest performance, SESN shares gained by 140.43% in over the last four-week period, additionally plugging by 104.88% over the last 6 months – not to mention a rise of 138.52% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SESN stock in for the last two-week period is set at 91.60, with the RSI for the last a single of trading hit 48.23, and the three-weeks RSI is set at 49.49 for Sesen Bio Inc. [SESN]. The present Moving Average for the last 50 days of trading for this stock 0.5942, while it was recorded at 0.5915 for the last single week of trading, and 0.6130 for the last 200 days.
Sesen Bio Inc. [SESN]: An insightful look at the core fundamentals
Sesen Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.10 and a Current Ratio set at 6.10.
Sesen Bio Inc. [SESN]: Insider Ownership positions
There are presently around $19 million, or 12.90% of SESN stock, in the hands of institutional investors. The top three institutional holders of SESN stocks are: VANGUARD GROUP INC with ownership of 10,854,300, which is approximately 0.039% of the company’s market cap and around 0.10% of the total institutional ownership; BML CAPITAL MANAGEMENT, LLC, holding 8,227,969 shares of the stock with an approximate value of $4.82 million in SESN stocks shares; and BLACKROCK INC., currently with $1.54 million in SESN stock with ownership of nearly -37.528% of the company’s market capitalization.
Positions in Sesen Bio Inc. stocks held by institutional investors increased at the end of Tuesday and at the time of the Tuesday reporting period, where 21 institutional holders increased their position in Sesen Bio Inc. [NASDAQ:SESN] by around 9,773,384 shares. Additionally, 37 investors decreased positions by around 3,140,387 shares, while 25 investors held positions by with 19,613,330 shares. The mentioned changes placed institutional holdings at 32,527,101 shares, according to the latest SEC report filing. SESN stock had 13 new institutional investments in for a total of 8,886,264 shares, while 12 institutional investors sold positions of 814,360 shares during the same period.